Hemoglobin A1c and Fructosamine Evaluated in Patients with Type 2 Diabetes Receiving Peritoneal Dialysis Using Long-Term Continuous Glucose Monitoring.
Sign Up to like & getrecommendations! Published in 2021 at "Nephron"
DOI: 10.1159/000519493
Abstract: INTRODUCTION Shortened erythrocyte life span and erythropoietin-stimulating agents may affect hemoglobin A1c (HbA1c) levels in patients receiving peritoneal dialysis (PD). We compared HbA1c with interstitial glucose measured by continuous glucose monitoring (CGM) in patients with… read more here.
Keywords: diabetes receiving; patients type; hemoglobin a1c; type diabetes ... See more keywords